144 related articles for article (PubMed ID: 38760707)
21. Does N-terminal Pro-brain Type Natriuretic Peptide Predict Cardiac Complications After Hip Fracture Surgery?
Ushirozako H; Ohishi T; Fujita T; Suzuki D; Yamamoto K; Banno T; Takase H; Matsuyama Y
Clin Orthop Relat Res; 2017 Jun; 475(6):1730-1736. PubMed ID: 28101755
[TBL] [Abstract][Full Text] [Related]
22. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
[TBL] [Abstract][Full Text] [Related]
24. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
25. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.
Shafi T; Zager PG; Sozio SM; Grams ME; Jaar BG; Christenson RH; Boulware LE; Parekh RS; Powe NR; Coresh J
Am J Kidney Dis; 2014 Sep; 64(3):443-51. PubMed ID: 24787760
[TBL] [Abstract][Full Text] [Related]
26. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
[TBL] [Abstract][Full Text] [Related]
27. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
[TBL] [Abstract][Full Text] [Related]
28. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
29. Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.
Chen L; Chen YY; Ling YS; Lin CH; He JX; Guan TJ
Ren Fail; 2017 Nov; 39(1):372-378. PubMed ID: 28209075
[TBL] [Abstract][Full Text] [Related]
30. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
Takase H; Dohi Y
Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
[TBL] [Abstract][Full Text] [Related]
31. NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease.
Shimohata H; Usui J; Tawara-Iida T; Ebihara I; Ishizu T; Maeda Y; Kobayashi H; Numajiri D; Kaneshige A; Sega M; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M; Yamagata K;
Clin Exp Nephrol; 2024 May; 28(5):457-464. PubMed ID: 38238500
[TBL] [Abstract][Full Text] [Related]
32. [Predictive value of CONUT score and dialysis age for peritoneal dialysis-associated peritonitis].
Wu AH; Mu XD; Chao WY; Lu PY; Yang M; Zhou H
Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):720-726. PubMed ID: 36889684
[No Abstract] [Full Text] [Related]
33. N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients.
Satoh A; Doi S; Naito T; Nakashima A; Masaki T
Clin Exp Nephrol; 2021 Oct; 25(10):1142-1150. PubMed ID: 34106372
[TBL] [Abstract][Full Text] [Related]
34. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
[TBL] [Abstract][Full Text] [Related]
35. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
36. Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.
Wang K; Li HL; Chen LL; Bei WJ; Lin KY; Smyth B; Chen SQ; Guo XS; Guo W; Liu YH; Chen PY; Chen JY; Chen KH; Liu Y; Tan N
Medicine (Baltimore); 2017 Mar; 96(10):e6259. PubMed ID: 28272231
[TBL] [Abstract][Full Text] [Related]
37. Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients.
Schachner T; Wiedemann D; Fetz H; Laufer G; Kocher A; Bonaros N
Clinics (Sao Paulo); 2010; 65(12):1239-45. PubMed ID: 21340210
[TBL] [Abstract][Full Text] [Related]
38. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
39. Predictors of Short-term Outcomes of Patients with Peritoneal Dialysis-associated Peritonitis.
Ma Y; Wang Y; Wang HY; Li Y; Zhou ZJ; Liu BY; Li XM; Chen LM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):13-20. PubMed ID: 29532776
[TBL] [Abstract][Full Text] [Related]
40. [Clinical Outcome and Risk Factors of Treatment Failure of Peritoneal Dialysis Associated Peritonitis Caused by
Yuan HZ; Zhu XY; Yang LM; Zhang XX; Li XY; Xie T; Zhai JZ; Zhuang XH; Cui WP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):227-234. PubMed ID: 37157069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
